You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Selenium-derivatized New Reagents for Nucleic Acid X-ray Crystallography
SBC: SENA RESEARCH, INC. Topic: NIEHSDESCRIPTION provided by applicant There are growing demands for D structure determination of nucleic acids and their protein complexes for understanding disease molecule level mechanisms and discovering innovative drugs X ray crystallography is one of the most direct and powerful tools for structure determination of these macromolecules and complexes However the crystallization and phase d ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Enhanced multiphoton microscopy through spatial light modulation
SBC: BOULDER NONLINEAR SYSTEMS, INC. Topic: 102DESCRIPTION provided by applicant Nonlinear optical microscopy techniques and particularly multiphoton fluorescence microscopy have become popular tools for visualizing the three dimensional cellular architecture residing hundreds of microns and up to one millimeter deep in living organisms This is particularly valuable in neurobiology where multiphoton techniques have become widely used fo ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
High-specificity affinity reagents for the detection of glycan sialylation
SBC: GLYCOSENSORS AND DIAGNOSTICS, LLC Topic: 300DESCRIPTION provided by applicant Glycans have several distinct properties that make their development as disease biomarkers appealing Firstly their location on cell surfaces makes them the first point of contact for cellular interactions and thus they are crucial in the control of normal metabolic processes and conversely they function as pathogen adhesion receptors Secondly specific gl ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Manufacturing pathogen inactivated platelet lysate to treat corneal inflammation
SBC: Cambium Medical Technologies LLC Topic: NDESCRIPTION provided by applicant Ocular graft versus host disease O GVHD is a particularly severe and debilitating complication of allogeneic hematopoietic stem cell transplantation HSCT O GVHD develops in of patients with chronic GVHD Currently Restasis cyclosporine A is the only FDA approved prescription topical medication to treat O GVHD In Restasis had sales o ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Scientific Merit and Feasibility of Fructokinase Inhibiton for Obesity
SBC: COLORADO RESEARCH PARTNERS LLC Topic: NIDDKDESCRIPTION provided by applicant Intake of added sweeteners high fructose corn syrup and sucrose independently predicts the development of obesity metabolic syndrome and diabetes Despite recommendations by WHO and the AHA to reduce sugar intake to to percent of total energy intake the mean intake of added sugars remains percent of the diet and percent of the population ingest ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Smartphone Technology for Parents and Teens: Improving Vaccination Uptake
SBC: KLEIN BUENDEL, INC. Topic: NICHDDESCRIPTION provided by applicant Vaccinations for adolescents in the U S tetanus diphtheria and acellular pertussis Tdap meningococcal conjugate vaccine MCV Human Papillomavirus HPV vaccines Gardasil and Cervarex remain well below the Centers for Disease Control and Prevention CDC goals and especially so for the HPV vaccines These vaccine deficits are pronounced among minor ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Anti-CXCL13 mAb to mitigate prostate cancer health disparities
SBC: JYANT Technologies, Inc. Topic: NIMHDDESCRIPTION provided by applicant The most common metastatic site for hormone refractory prostate cancer HRPC PCa is bone While docetaxel can prolong the overall survival in patients with metastatic HRPC current treatments do not provide a cure Further complicating the matter HRPC is a disease that affects a variety of patients differently which can be problematic for physicians to prov ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Nutritional Therapy in Elderly with Heart Failure
SBC: Essential Blends, LLC Topic: NIADESCRIPTION provided by applicant The long term goal of this project is to develop and test a nutritional product that will improve physical function in individuals with heart failure H in the geriatric population Our approach to nutritional therapy NT focuses on increasing skeletal muscle strength improving vascular reactivity and optimizing regulation of energy substrate metabolism All ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
STTR Phase I: Rapid Investment Casting of Superalloys Using Microwave Technology
SBC: HADRON TECHNOLOGIES, INC. Topic: MNThe broader impact/commercial potential of this Small Business Technology Transfer Research (STTR) Phase I project is aligned with revolutionizing the metal casting industry by demonstrating a novel rapid and versatile investment casting system. This all inclusive unit is based on a hybrid microwave heating technology which permits direct irradiation of the casting mold and metal melt, which resul ...
STTR Phase I 2015 National Science Foundation -
STTR Phase I: Development of a novel patient-operated, color-based, disposable diagnostic self-test for anemia
SBC: Sanguina, LLC Topic: BMThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is high and focuses on optimizing an inexpensive, disposable, home-based self-test for anemia that can potentially serve millions of people in the U.S. suffering from anemia, including patients with blood diseases, chronic kidney disease, HIV/AIDS, cancer, and inflammatory diseases.. This scre ...
STTR Phase I 2015 National Science Foundation